Esther Holgado - Researcher Profile | RDL Research Database

Publications

2 shown

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei , L. Paz-Ares , Leora Horn +25 more

Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (...

2015 New England Journal of Medicine 9225 citations

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer , Karen L. Reckamp , Paul Baas +22 more

Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab tha...

2015 New England Journal of Medicine 8355 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 17,580
Institution: Hospital Universitario HM Sanchinarro

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7008-7135

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.